Published in J Hypertens on April 01, 2006
Ethnic differences in arterial wave reflections and normative equations for augmentation index. Hypertension (2011) 1.77
Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol (2008) 1.75
Ethnic differences in carotid artery diameter and stiffness: the Northern Manhattan Study. Atherosclerosis (2011) 0.95
Relationships between pulse wave velocity and heart rate variability in healthy men with a range of moderate-to-vigorous physical activity levels. Eur J Appl Physiol (2006) 0.89
Age- and gender-specific reference values of pulse wave velocity for African adults: preliminary results. Age (Dordr) (2013) 0.84
Influence on aerobic fitness on aortic stiffness in apparently healthy Caucasian and African-American subjects. Int J Cardiol (2007) 0.82
Smoking and vascular dysfunction in Africans and Caucasians from South Africa. Cardiovasc J Afr (2011) 0.81
Inflammation as Possible Mediator for the Relationship Between Lung and Arterial Function. Lung (2015) 0.77
The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus. Lupus (2009) 0.77
Do arterial stiffness and wave reflection underlie cardiovascular risk in ethnic minorities? JRSM Cardiovasc Dis (2016) 0.75
Arterial waveform parameters in a large, population-based sample of adults: relationships with ethnicity and lifestyle factors. J Hum Hypertens (2016) 0.75
Assessment of Systolic and Diastolic Cardiac Function beyond Traditional Markers in Hypertensive Patients. Role of Cardiac Reserve. Maedica (Buchar) (2013) 0.75
Can arterial wave augmentation in young adults help account for variability of cardiovascular risk in different British ethnic groups? J Hypertens (2016) 0.75
Smoking Behaviors and Arterial Stiffness Measured by Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Hypertens (2015) 0.75
Central Hemodynamics for Management of Arteriosclerotic Diseases. J Atheroscler Thromb (2017) 0.75
Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation. J Hypertens (2004) 2.74
Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med (2006) 2.74
Amplification of the pressure pulse in the upper limb in healthy, middle-aged men and women. Hypertension (2009) 2.59
Acute effects of passive smoking on peripheral vascular function. Hypertension (2008) 2.25
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens (2002) 2.00
Stroke prevention, treatment, and rehabilitation in sub-saharan Africa. Am J Prev Med (2005) 1.99
Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation (2004) 1.79
Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. J Hypertens (2003) 1.78
Ethnic differences in arterial wave reflections and normative equations for augmentation index. Hypertension (2011) 1.77
Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transplantation (2002) 1.55
Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction. J Cardiovasc Pharmacol (2009) 1.51
Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders. Am J Physiol Heart Circ Physiol (2006) 1.50
Effects of hunter-gatherer subsistence mode on arterial distensibility in Cameroonian pygmies. Hypertension (2012) 1.44
Sympathoexcitation increases the QT/RR slope in healthy men: differential effects of hypoxia, dobutamine, and phenylephrine. J Cardiovasc Electrophysiol (2007) 1.43
Home medication cabinets and self-medication: a source of potential health threats? Ann Pharmacother (2008) 1.39
Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells (2005) 1.19
Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.19
Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. Circ Cardiovasc Genet (2011) 1.11
Causal relationships between heart period and systolic arterial pressure during graded head-up tilt. Am J Physiol Regul Integr Comp Physiol (2010) 1.09
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. Br J Clin Pharmacol (2009) 1.07
Retracted AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics. Anesthesiology (2005) 1.07
Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies. Am J Trop Med Hyg (2009) 1.06
Acute arterio-venous fistula occlusion decreases sympathetic activity and improves baroreflex control in kidney transplanted patients. Nephrol Dial Transplant (2004) 1.03
COPD management in primary care: an observational, community pharmacy-based study. Ann Pharmacother (2010) 1.02
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag (2011) 1.02
Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol (2014) 1.01
Arteriovenous fistula closure after renal transplantation: a prospective study with 24-hour ambulatory blood pressure monitoring. Transplantation (2008) 0.98
Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension (2006) 0.96
Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.96
Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up. Am J Transplant (2004) 0.95
Environmental determinants of blood pressure, arterial stiffness, and central hemodynamics. J Hypertens (2010) 0.95
Evaluation of standard and modified severity of illness scores in the obstetric patient. J Crit Care (2010) 0.95
[Hypertension in the adult Congolese population of Southern Kivu: Results of the Vitaraa Study]. Presse Med (2011) 0.94
Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men. Hypertension (2005) 0.94
Interdependency between heart rate variability and sleep EEG: linear/non-linear? Clin Neurophysiol (2004) 0.93
Nicotine increases chemoreflex sensitivity to hypoxia in non-smokers. J Hypertens (2008) 0.92
Elevated prevalence of arterial hypertension amongst Belgian taxi drivers during the World Hypertension Day campaign 2006. J Hypertens (2006) 0.92
Acute exposure to diesel exhaust impairs nitric oxide-mediated endothelial vasomotor function by increasing endothelial oxidative stress. Hypertension (2013) 0.91
Hyperoxia enhances metaboreflex sensitivity during static exercise in humans. Am J Physiol Heart Circ Physiol (2006) 0.91
Elevated prevalence of arterial hypertension in the Belgian parliament. J Hypertens (2005) 0.91
Arterial stiffness and wave reflections in patients with sickle cell disease. Hypertension (2004) 0.90
Prevalence of hypertension and cardiovascular risk factors in Belgian civil employees: results of the screening during World Hypertension Day 2007. J Hypertens (2008) 0.90
Effect of beta-adrenergic stimulation on pulse wave velocity in black and white subjects. J Hypertens (2004) 0.90
Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens (2005) 0.90
A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant (2013) 0.89
Endothelin receptor blockade in canine oleic acid-induced lung injury. Intensive Care Med (2003) 0.88
Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. Eur J Clin Pharmacol (2011) 0.88
Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon. Vasc Health Risk Manag (2013) 0.88
MR pulse wave velocity increases with age faster in the thoracic aorta than in the abdominal aorta. J Magn Reson Imaging (2014) 0.88
Increased metaboreflex activity is related to exercise intolerance in heart transplant patients. Am J Physiol Heart Circ Physiol (2007) 0.87
Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol (2011) 0.87
Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension. Chest (2007) 0.87
Retracted AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety. Anesthesiology (2005) 0.86
New insights into the sympathetic, endothelial and coronary effects of nicotine. Clin Exp Pharmacol Physiol (2008) 0.86
Increased peripheral chemoreceptors sensitivity and exercise ventilation in heart transplant recipients. Circulation (2006) 0.85
Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med (2005) 0.85
Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects. Antivir Ther (2014) 0.84
Drug utilization in Belgian nursing homes: impact of residents' and institutional characteristics. Pharmacoepidemiol Drug Saf (2010) 0.84
Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention (2013) 0.83
Carotid tonometry versus synthesized aorta pressure waves for the estimation of central systolic blood pressure and augmentation index. Am J Hypertens (2005) 0.83
Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults. J Clin Pharmacol (2010) 0.83
Chemoreflex and metaboreflex control during static hypoxic exercise. Am J Physiol Heart Circ Physiol (2004) 0.83
Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans. Am J Physiol Heart Circ Physiol (2003) 0.82
Blood pressure waveform analysis by means of wavelet transform. Med Biol Eng Comput (2008) 0.82
Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSYST survey. J Hypertens (2008) 0.82
Focus on small artery stiffness. J Hypertens (2002) 0.82
Vitamin D deficiency-induced hypertension is associated with vascular oxidative stress and altered heart gene expression. J Cardiovasc Pharmacol (2011) 0.81
Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs. Crit Care (2004) 0.81
Naftidrofuryl for intermittent claudication. Cochrane Database Syst Rev (2012) 0.81
Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation. Expert Opin Investig Drugs (2008) 0.81
Effects of peripheral chemoreceptors deactivation on sympathetic activity in heart transplant recipients. Hypertension (2005) 0.81
Where are we with the management of hypertension? From science to clinical practice. J Clin Hypertens (Greenwich) (2009) 0.81
The effect of different intensity modalities of resistance training on beat-to-beat blood pressure in cardiac patients. Eur J Cardiovasc Prev Rehabil (2005) 0.80
Quality of prescribing in Belgian nursing homes: an electronic assessment of the medication chart. Int J Qual Health Care (2013) 0.80
Self-medication of upper gastrointestinal symptoms: a community pharmacy study. Ann Pharmacother (2009) 0.80
Scale-free dynamics of the synchronization between sleep EEG power bands and the high frequency component of heart rate variability in normal men and patients with sleep apnea-hypopnea syndrome. Clin Neurophysiol (2007) 0.80
Functional analysis of the common carotid artery: relative distension differences over the vessel wall measured in vivo. J Hypertens (2004) 0.80
Effects of antiretroviral therapy on arterial stiffness in Cameroonian HIV-infected patients. Blood Press Monit (2013) 0.80
Association of menopause and hormone replacement therapy with large artery remodeling. Fertil Steril (2011) 0.80
Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study. Eur J Clin Pharmacol (2014) 0.80
The COMmon control of hypErtenSion and Therapeutic Attitudes in BelgIum and Luxemburg study (COME STAI). Acta Cardiol (2016) 0.80